To evaluate the association between PD-L1 expression and response to therapy, pre-treatment tumor specimens from 42 patients were immunohistochemically stained for PD-L1 expression 36% of PD-L1-positive patients and none of the PD-L1-negative patients were responders [12]. Here, CD274 is linked to neoplasm.